首页 > 最新文献

The Journal of Internal Korean Medicine最新文献

英文 中文
Safety of Herbal Medicines on Liver Function in Functional Dyspepsia Patients: A Single-Center Retrospective Study 中药对功能性消化不良患者肝功能的安全性:一项单中心回顾性研究
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.635
Aram Han, Chang-Yul Keum, Chae-Rim Yoon, Su-Hyun Choi, Dahee Jeong, Nahyun Jeong, Hae-in Jeong, Na-Yeon Ha, Jinsung Kim
Objectives: This study analyzed laboratory serum data results before and after patients took herbal medicine to confirm the clinical safety of herbal medicine. In addition, in the event of liver damage, the case was analyzed to confirm the characteristics of liver damage and the possibility of liver damage caused by herbal medicine.Methods: A retrospective chart review of the effects of herbal medicine on liver function in patients diagnosed with functional dyspepsia was conducted. The electronic medical records of 128 patients in a single hospital were reviewed.Results: The statistical analysis revealed a statistically significant decrease in liver function-related laboratory serum data after taking herbal medicine (p<0.05). In addition, among 128 patients, there were two cases of drug-induced liver injury (DILI) (1.56%).Conclusion: Taking herbal medicine prescribed by experts does not significantly affect liver function in patients with functional dyspepsia. Rather, the liver levels of the subjects showed a significant decrease after taking herbal medicine. To support these results, further large-scale multicenter prospective studies are necessary.
目的:分析患者服用中药前后的实验室血清数据结果,以证实中药的临床安全性。此外,在发生肝损害的情况下,对病例进行分析,以确认肝损害的特点和草药引起肝损害的可能性。方法:回顾性分析中药对功能性消化不良患者肝功能的影响。对一家医院128名患者的电子病历进行了审查。结果:经统计学分析,服用中药后肝功能相关实验室血清数据下降有统计学意义(p<0.05)。此外,128例患者中,药物性肝损伤(DILI) 2例(1.56%)。结论:功能性消化不良患者服用专家处方中草药对肝功能无明显影响。相反,服用草药后,受试者的肝脏水平明显下降。为了支持这些结果,进一步的大规模多中心前瞻性研究是必要的。
{"title":"Safety of Herbal Medicines on Liver Function in Functional Dyspepsia Patients: A Single-Center Retrospective Study","authors":"Aram Han, Chang-Yul Keum, Chae-Rim Yoon, Su-Hyun Choi, Dahee Jeong, Nahyun Jeong, Hae-in Jeong, Na-Yeon Ha, Jinsung Kim","doi":"10.22246/jikm.2023.44.4.635","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.635","url":null,"abstract":"Objectives: This study analyzed laboratory serum data results before and after patients took herbal medicine to confirm the clinical safety of herbal medicine. In addition, in the event of liver damage, the case was analyzed to confirm the characteristics of liver damage and the possibility of liver damage caused by herbal medicine.Methods: A retrospective chart review of the effects of herbal medicine on liver function in patients diagnosed with functional dyspepsia was conducted. The electronic medical records of 128 patients in a single hospital were reviewed.Results: The statistical analysis revealed a statistically significant decrease in liver function-related laboratory serum data after taking herbal medicine (p<0.05). In addition, among 128 patients, there were two cases of drug-induced liver injury (DILI) (1.56%).Conclusion: Taking herbal medicine prescribed by experts does not significantly affect liver function in patients with functional dyspepsia. Rather, the liver levels of the subjects showed a significant decrease after taking herbal medicine. To support these results, further large-scale multicenter prospective studies are necessary.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"130 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of Combined Administration of Hypoglycemic Agents and Herbal Extracts (<i>Pyeongwi-san</i> or <i>HyangsaPyongwi-san</i>) on Blood Glucose Levels in Type 2 Diabetes Mellitus: A Retrospective Study 降糖药与草药提取物联合应用的评价(&lt;i&gt;Pyeongwi-san&lt;/i&gt;HyangsaPyongwi-san&lt;/i&gt;)对2型糖尿病血糖水平的影响:一项回顾性研究
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.661
Woo-nyoung Jung, Seung-hyun Oh, Mee-ryoung Song, Ji-won Noh, Young-min Ahn, Se-young Ahn, Byung-cheol Lee
Abstract: This retrospective study delved into the effects and safety considerations associated with the concomitant usage of hypoglycemic agents and herbal extracts, specifically Pyeongwi-san (PWS) or HyangsaPyongwi-san (HSPWS) in the context of type 2 diabetes mellitus management.Methods: The investigation involved 38 inpatients with type 2 diabetes mellitus who received PWS or HSPWS treatment at Kyung Hee University Korean Medical Hospital from January 2012 to December 2022. By investigating clinical attributes and conducting laboratory assessments, this study aimed to discern the impact of these herbal extracts on blood glucose levels, encompassing fasting blood sugar (FBS) and mean 2-hour postprandial glucose (PP2) levels. Furthermore, the safety profile of the herbal extracts was assessed by comparing liver function indicators, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transferase (GGT), alongside kidney function markers, such as blood urea nitrogen (BUN) and creatinine (Cr).Results: Following the administration of the herbal extracts, no statistically significant alterations in FBS and mean PP2 levels emerged compared to the baseline levels. Notably, the safety evaluation revealed no significant differences in liver and kidney function parameters following herbal extract administration.Conclusion: The results of this research indicate that using PWS or HSPWS alongside hypoglycemic medications could be a beneficial additional method for addressing digestive symptoms in individuals with type 2 diabetes mellitus. Notably, this combination seems to have no negative interactions with other drugs.
摘要:本回顾性研究探讨了降糖药和草药提取物同时使用的疗效和安全性,特别是平威山。(PWS)或<i>HyangsaPyongwi-san</i>(HSPWS)在2型糖尿病管理中的应用。方法:对2012年1月至2022年12月在庆熙大学高丽医院接受PWS或HSPWS治疗的38例2型糖尿病住院患者进行调查。通过调查临床属性并进行实验室评估,本研究旨在了解这些草药提取物对血糖水平的影响,包括空腹血糖(FBS)和平均餐后2小时血糖(PP2)水平。此外,通过比较肝功能指标(包括天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和γ-谷氨酰转移酶(GGT))以及肾功能指标(如血尿素氮(BUN)和肌酐(Cr))来评估草药提取物的安全性。结果:服用草药提取物后,与基线水平相比,FBS和平均PP2水平没有统计学意义的变化。值得注意的是,安全性评估显示,服用草药提取物后,肝肾功能参数没有显著差异。结论:本研究结果表明,PWS或HSPWS与降糖药物一起使用可能是解决2型糖尿病患者消化系统症状的一种有益的额外方法。值得注意的是,这种组合似乎与其他药物没有负面相互作用。
{"title":"Assessment of Combined Administration of Hypoglycemic Agents and Herbal Extracts (&lt;i&gt;Pyeongwi-san&lt;/i&gt; or &lt;i&gt;HyangsaPyongwi-san&lt;/i&gt;) on Blood Glucose Levels in Type 2 Diabetes Mellitus: A Retrospective Study","authors":"Woo-nyoung Jung, Seung-hyun Oh, Mee-ryoung Song, Ji-won Noh, Young-min Ahn, Se-young Ahn, Byung-cheol Lee","doi":"10.22246/jikm.2023.44.4.661","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.661","url":null,"abstract":"Abstract: This retrospective study delved into the effects and safety considerations associated with the concomitant usage of hypoglycemic agents and herbal extracts, specifically <i>Pyeongwi-san</i> (PWS) or <i>HyangsaPyongwi-san</i> (HSPWS) in the context of type 2 diabetes mellitus management.Methods: The investigation involved 38 inpatients with type 2 diabetes mellitus who received PWS or HSPWS treatment at Kyung Hee University Korean Medical Hospital from January 2012 to December 2022. By investigating clinical attributes and conducting laboratory assessments, this study aimed to discern the impact of these herbal extracts on blood glucose levels, encompassing fasting blood sugar (FBS) and mean 2-hour postprandial glucose (PP2) levels. Furthermore, the safety profile of the herbal extracts was assessed by comparing liver function indicators, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transferase (GGT), alongside kidney function markers, such as blood urea nitrogen (BUN) and creatinine (Cr).Results: Following the administration of the herbal extracts, no statistically significant alterations in FBS and mean PP2 levels emerged compared to the baseline levels. Notably, the safety evaluation revealed no significant differences in liver and kidney function parameters following herbal extract administration.Conclusion: The results of this research indicate that using PWS or HSPWS alongside hypoglycemic medications could be a beneficial additional method for addressing digestive symptoms in individuals with type 2 diabetes mellitus. Notably, this combination seems to have no negative interactions with other drugs.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Practice Patterns for Benign Prostatic Hyperplasia: An Online Survey 良性前列腺增生的临床实践模式:在线调查
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.703
Ji-soo Baek, Seon-mi Shin, Chung-sik Cho
Objectives: This study investigated Korean medicine doctors’ perspectives on clinical practice patterns in the process of developing Korean medicine clinical practice guidelines for benign prostatic hyperplasia.Methods: A questionnaire was developed for Korean medicine doctors. A total of 323 oriental medicine doctors participated in the survey, which was live for a total of 9 days from September 22, 2022, to September 30, 2022.Results: Regarding awareness of treatments for benign prostatic hyperplasia, 63.8% of respondents showed high awareness of Korean medical treatments. However, items such as diagnostic criteria (17.7%), evaluation methods (17.0%), and Western medical treatments (22.9%) showed low recognition rates. In clinical practice, 76.2% of respondents were found to treat five or fewer patients with benign prostatic hyperplasia per month, and the average treatment period was 1 to 3 months for most at 41.2%. Korean medicine doctors diagnosed benign prostatic hyperplasia based on clinical features. The main interventions used were acupuncture, herbal medicine (prescription medicine), and moxibustion. This study has several limitations because of the low response rate for this survey; therefore, the participants are not representative of all Korean medicine doctors. In addition, because the study was conducted broadly on various topics related to benign prostatic hyperplasia, sufficient quality management was not carried out. Further studies that include a larger sample size and more in-depth studies on benign prostatic hyperplasia are needed.Conclusions: It is necessary to develop appropriate and reasonable Korean medicine clinical practice guidelines for benign prostatic hyperplasia.
目的:探讨韩医医师在制定良性前列腺增生韩医临床实践指南过程中对临床实践模式的看法。方法:对韩医医师进行问卷调查。共有323名东方医学医生参与了调查,从2022年9月22日到9月30日共进行了9天的现场调查。结果:在对良性前列腺增生治疗的认知度方面,63.8%的受访者对韩国医疗的认知度较高。而诊断标准(17.7%)、评价方法(17.0%)、西医治疗(22.9%)等项目的认知率较低。在临床实践中,76.2%的受访者发现每月治疗5例及以下良性前列腺增生患者,平均治疗时间为1至3个月,占41.2%。韩国医生根据临床特征诊断为良性前列腺增生。使用的主要干预措施是针灸、草药(处方药)和艾灸。由于本调查的回复率低,本研究存在一些局限性;因此,参加者并不能代表所有的韩国医生。此外,由于本研究涉及的良性前列腺增生相关课题比较广泛,没有进行足够的质量管理。需要进一步的研究,包括更大的样本量和更深入的研究良性前列腺增生。结论:有必要制定适当、合理的韩医良性前列腺增生临床诊疗指南。
{"title":"Clinical Practice Patterns for Benign Prostatic Hyperplasia: An Online Survey","authors":"Ji-soo Baek, Seon-mi Shin, Chung-sik Cho","doi":"10.22246/jikm.2023.44.4.703","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.703","url":null,"abstract":"Objectives: This study investigated Korean medicine doctors’ perspectives on clinical practice patterns in the process of developing Korean medicine clinical practice guidelines for benign prostatic hyperplasia.Methods: A questionnaire was developed for Korean medicine doctors. A total of 323 oriental medicine doctors participated in the survey, which was live for a total of 9 days from September 22, 2022, to September 30, 2022.Results: Regarding awareness of treatments for benign prostatic hyperplasia, 63.8% of respondents showed high awareness of Korean medical treatments. However, items such as diagnostic criteria (17.7%), evaluation methods (17.0%), and Western medical treatments (22.9%) showed low recognition rates. In clinical practice, 76.2% of respondents were found to treat five or fewer patients with benign prostatic hyperplasia per month, and the average treatment period was 1 to 3 months for most at 41.2%. Korean medicine doctors diagnosed benign prostatic hyperplasia based on clinical features. The main interventions used were acupuncture, herbal medicine (prescription medicine), and moxibustion. This study has several limitations because of the low response rate for this survey; therefore, the participants are not representative of all Korean medicine doctors. In addition, because the study was conducted broadly on various topics related to benign prostatic hyperplasia, sufficient quality management was not carried out. Further studies that include a larger sample size and more in-depth studies on benign prostatic hyperplasia are needed.Conclusions: It is necessary to develop appropriate and reasonable Korean medicine clinical practice guidelines for benign prostatic hyperplasia.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"14 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082875","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bowel Perforation Treated with Acupuncture and <i>Gami-Gamchogungang-tang</i> : A Case Report 针灸治疗肠穿孔&lt;i&gt; gamchogungang -tang&lt;/i&gt;: 1例报告
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.814
Hyun-sik Seo, Jun-yeol Kim, Han-eum Ju, Young-min Jo, Hye-ri Bae, Jung-hyo Cho
Objective: This case report details the successful management of bowel perforation through traditional Korean medicine. Often, emergency surgery is required due to potential complications, such as peritonitis. In this case, the patient had previously undergone a total colectomy, making surgical treatment complicated.Methods: The patient revealed persistent abdominal pain and over 20 instances of diarrhea per day. During the course of treatment, which included two hospitalizations and one outpatient visit, acupuncture treatment and herbal medicine were administered. Throughout the treatment period, the intensity of abdominal pain and the frequency of diarrhea gradually decreased.Results: At the end of treatment, a follow-up abdominal computed tomography (CT) scan showed no evidence of perforation. Additionally, blood tests revealed no abnormalities in liver or kidney function, confirming the safety of the treatments.
目的:本病例报告详细介绍了韩国传统药物治疗肠穿孔的成功方法。通常,由于潜在的并发症,如腹膜炎,需要紧急手术。在这个病例中,患者之前接受了全结肠切除术,使得手术治疗变得复杂。方法:患者表现为持续腹痛,每日腹泻20余例。在治疗过程中,包括两次住院和一次门诊,针灸治疗和草药治疗。在整个治疗期间,腹痛的强度和腹泻的频率逐渐减少。结果:在治疗结束时,随访腹部计算机断层扫描(CT)显示没有穿孔的证据。此外,血液检查显示肝脏或肾脏功能没有异常,证实了治疗的安全性。
{"title":"Bowel Perforation Treated with Acupuncture and &lt;i&gt;Gami-Gamchogungang-tang&lt;/i&gt; : A Case Report","authors":"Hyun-sik Seo, Jun-yeol Kim, Han-eum Ju, Young-min Jo, Hye-ri Bae, Jung-hyo Cho","doi":"10.22246/jikm.2023.44.4.814","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.814","url":null,"abstract":"Objective: This case report details the successful management of bowel perforation through traditional Korean medicine. Often, emergency surgery is required due to potential complications, such as peritonitis. In this case, the patient had previously undergone a total colectomy, making surgical treatment complicated.Methods: The patient revealed persistent abdominal pain and over 20 instances of diarrhea per day. During the course of treatment, which included two hospitalizations and one outpatient visit, acupuncture treatment and herbal medicine were administered. Throughout the treatment period, the intensity of abdominal pain and the frequency of diarrhea gradually decreased.Results: At the end of treatment, a follow-up abdominal computed tomography (CT) scan showed no evidence of perforation. Additionally, blood tests revealed no abnormalities in liver or kidney function, confirming the safety of the treatments.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of Korean Medicine Treatment Including <i>Samchulgunbi-tang-gagambang</i> in a Patient with Vestibular Neuritis 韩药治疗包括“Samchulgunbi-tang-gagambang&lt;/i&gt;前庭神经炎患者
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.757
Ye-seul Park, Jeong-hui Kim, Ju-yeon Song, Ho-ryong Yoo, In-chan Seol, Yoon-sik Kim
Background: Vestibular neuritis is a common cause of acute unilateral peripheral vestibulopathy. Vestibular neuritis is the second most common disease among patients with dizziness. Clinical symptoms of vestibular neuritis include the sudden onset of vertigo with spontaneous nystagmus, unsteady gait, nausea, and vomiting that last from days to weeks. However, even after the vertigo disappears, difficulty maintaining balance while walking may persist for weeks to months. Antihistamines, serotonin receptor blockers, and benzodiazepine vestibular suppressants are widely used as symptomatic treatments to reduce the severity of symptoms that occur in the acute phase.Case Summary: A patient diagnosed with acute vestibular neuritis was treated with acupuncture, moxibustion, and herbal medicine. We used the visual analog scale (VAS) to assess each symptom and the vertigo score to observe the effect of treatment. After treatment, the VAS scores for each symptom and the vertigo score decreased, and the severity of nystagmus was reduced.Conclusion: This study suggests that Korean medicine treatments, including Samchulgunbi-tang-gagam, could be effective in improving the clinical symptoms of vestibular neuritis.
背景:前庭神经炎是急性单侧周围性前庭病变的常见病因。前庭神经炎是眩晕患者中第二常见的疾病。前庭神经炎的临床症状包括突发性眩晕伴自发性眼球震颤、步态不稳、恶心和呕吐,持续数天至数周。然而,即使在眩晕消失后,行走时保持平衡的困难可能会持续数周到数月。抗组胺药、血清素受体阻滞剂和苯二氮卓类前庭抑制剂被广泛用于对症治疗,以减轻急性期出现的症状的严重程度。病例总结:一例诊断为急性前庭神经炎的患者,采用针刺、艾灸、中药治疗。采用视觉模拟评分法(VAS)对各症状进行评分,眩晕评分观察治疗效果。治疗后,各症状VAS评分及眩晕评分均下降,眼球震颤严重程度减轻。结论:本研究提示韩药治疗对改善前庭神经炎的临床症状是有效的。
{"title":"A Case Report of Korean Medicine Treatment Including &lt;i&gt;Samchulgunbi-tang-gagambang&lt;/i&gt; in a Patient with Vestibular Neuritis","authors":"Ye-seul Park, Jeong-hui Kim, Ju-yeon Song, Ho-ryong Yoo, In-chan Seol, Yoon-sik Kim","doi":"10.22246/jikm.2023.44.4.757","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.757","url":null,"abstract":"Background: Vestibular neuritis is a common cause of acute unilateral peripheral vestibulopathy. Vestibular neuritis is the second most common disease among patients with dizziness. Clinical symptoms of vestibular neuritis include the sudden onset of vertigo with spontaneous nystagmus, unsteady gait, nausea, and vomiting that last from days to weeks. However, even after the vertigo disappears, difficulty maintaining balance while walking may persist for weeks to months. Antihistamines, serotonin receptor blockers, and benzodiazepine vestibular suppressants are widely used as symptomatic treatments to reduce the severity of symptoms that occur in the acute phase.Case Summary: A patient diagnosed with acute vestibular neuritis was treated with acupuncture, moxibustion, and herbal medicine. We used the visual analog scale (VAS) to assess each symptom and the vertigo score to observe the effect of treatment. After treatment, the VAS scores for each symptom and the vertigo score decreased, and the severity of nystagmus was reduced.Conclusion: This study suggests that Korean medicine treatments, including <i>Samchulgunbi-tang-gagam</i>, could be effective in improving the clinical symptoms of vestibular neuritis.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"49 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Case Report of Korean Medicine Treatment for a Patient with Acute Cholangitis Accompanied by Common Bile Duct Stone 韩药治疗急性胆管炎合并胆总管结石1例报告
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.803
Na-Yeon Kim, Seung-Mo Kim, Kyung-Soon Kim
Objective: This case report outlines an investigation into the efficacy of Korean medicine treatment in a patient who presented with acute cholangitis accompanying common bile duct stones. The patient underwent percutaneous transhepatic gallbladder drainage and subsequently experienced resolution of the common bile duct stones.Methods: The patient was treated with Shihosogan-tang, general acupuncture, ear acupuncture, moxibustion, and cupping therapy. Changes in symptoms were evaluated using a self-reported numerical rating scale (NRS) score and a visual analog scale (VAS) score each morning. Laboratory tests were conducted to examine serum amylase, serum lipase, and liver function.Results: After 29 days, the NRS scores for indigestion and fatigue and the VAS score for abdominal pain all decreased. Additionally, the laboratory test results showed improvement.Discussion: The results suggest that Korean medicine could be effective in treating symptoms of acute cholangitis. However, further research is necessary.
目的:本病例报告概述了韩药治疗急性胆管炎合并胆总管结石的疗效。患者接受了经皮经肝胆囊引流术,随后胆总管结石得以清除。方法:对患者采用石草甘汤、普针、耳针、艾灸、拔罐等治疗方法。每天早上使用自我报告的数值评定量表(NRS)评分和视觉模拟量表(VAS)评分来评估症状的变化。实验室检查血清淀粉酶、血清脂肪酶和肝功能。结果:29 d后,消化不良评分、疲劳评分和腹痛VAS评分均下降。此外,实验室测试结果显示改善。讨论:结果提示韩药对急性胆管炎症状的治疗是有效的。然而,进一步研究是必要的。
{"title":"A Case Report of Korean Medicine Treatment for a Patient with Acute Cholangitis Accompanied by Common Bile Duct Stone","authors":"Na-Yeon Kim, Seung-Mo Kim, Kyung-Soon Kim","doi":"10.22246/jikm.2023.44.4.803","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.803","url":null,"abstract":"Objective: This case report outlines an investigation into the efficacy of Korean medicine treatment in a patient who presented with acute cholangitis accompanying common bile duct stones. The patient underwent percutaneous transhepatic gallbladder drainage and subsequently experienced resolution of the common bile duct stones.Methods: The patient was treated with <i>Shihosogan-tang</i>, general acupuncture, ear acupuncture, moxibustion, and cupping therapy. Changes in symptoms were evaluated using a self-reported numerical rating scale (NRS) score and a visual analog scale (VAS) score each morning. Laboratory tests were conducted to examine serum amylase, serum lipase, and liver function.Results: After 29 days, the NRS scores for indigestion and fatigue and the VAS score for abdominal pain all decreased. Additionally, the laboratory test results showed improvement.Discussion: The results suggest that Korean medicine could be effective in treating symptoms of acute cholangitis. However, further research is necessary.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Herbal Medicine on Sleep Disorders in Parkinson’s Disease: A Review of Randomized Controlled Trials 草药治疗帕金森病睡眠障碍的疗效:随机对照试验综述
Pub Date : 2023-09-30 DOI: 10.22246/jikm.2023.44.4.603
Ji-hyeon Kang, Kyungmin Baek
Objectives: This study reviewed randomized controlled trials (RCTs) investigating the efficacy of herbal medicine on sleep disorders associated with Parkinson’s disease and suggests a better research process.Methods: We searched for RCTs for herbal medicine treatments for sleep disorders related to Parkinson’s disease on July 31, 2023 using eight databases (PubMed, Embase, the Cochrane library, China National Knowledge Infrastructure [CNKI], the Research Information Service System [RISS], Science ON, the Oriental Medicine Advanced Searching Integrated System [OASIS], and the Korea Citation Index [KCI]). Cochrane’s risk of bias tool was used to assess the quality of the RCTs.Results: A total of 16 RCTs met all the inclusion criteria, and in most reports, the treatment group showed a significant improvement in sleep disorders compared to the control group. Total effective rate (TER), Pittsburgh Sleep Quality Index (PSQI), Unified Parkinson’s Disease Rating Scale (UPDRS), TCM Symptom Score (TSS), Parkinson’s Disease Sleep Scale (PDSS), etc., were used as evaluation indicators.Conclusion: Herbal medicine is a potential treatment for sleep disorders associated with Parkinson’s disease. However, the selected RCTs were of poor quality, and it is necessary to perform more systematic studies.
目的:本研究回顾了草药治疗帕金森病相关睡眠障碍的随机对照试验(rct),并提出了更好的研究过程。方法:我们于2023年7月31日使用8个数据库(PubMed、Embase、Cochrane图书馆、中国知网(CNKI)、研究信息服务系统(RISS)、Science on、东方医学高级检索集成系统(OASIS)和韩国引文索引(KCI))检索与帕金森病相关的睡眠障碍的草药治疗的随机对照试验。采用Cochrane偏倚风险工具评估随机对照试验的质量。结果:共有16项rct符合所有纳入标准,在大多数报告中,治疗组与对照组相比,睡眠障碍有显著改善。采用总有效率(TER)、匹兹堡睡眠质量指数(PSQI)、统一帕金森病评定量表(UPDRS)、中医症状评分(TSS)、帕金森病睡眠量表(PDSS)等作为评价指标。结论:草药是帕金森病相关睡眠障碍的潜在治疗方法。然而,所选择的rct质量较差,有必要进行更系统的研究。
{"title":"Efficacy of Herbal Medicine on Sleep Disorders in Parkinson’s Disease: A Review of Randomized Controlled Trials","authors":"Ji-hyeon Kang, Kyungmin Baek","doi":"10.22246/jikm.2023.44.4.603","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.4.603","url":null,"abstract":"Objectives: This study reviewed randomized controlled trials (RCTs) investigating the efficacy of herbal medicine on sleep disorders associated with Parkinson’s disease and suggests a better research process.Methods: We searched for RCTs for herbal medicine treatments for sleep disorders related to Parkinson’s disease on July 31, 2023 using eight databases (PubMed, Embase, the Cochrane library, China National Knowledge Infrastructure [CNKI], the Research Information Service System [RISS], Science ON, the Oriental Medicine Advanced Searching Integrated System [OASIS], and the Korea Citation Index [KCI]). Cochrane’s risk of bias tool was used to assess the quality of the RCTs.Results: A total of 16 RCTs met all the inclusion criteria, and in most reports, the treatment group showed a significant improvement in sleep disorders compared to the control group. Total effective rate (TER), Pittsburgh Sleep Quality Index (PSQI), Unified Parkinson’s Disease Rating Scale (UPDRS), TCM Symptom Score (TSS), Parkinson’s Disease Sleep Scale (PDSS), etc., were used as evaluation indicators.Conclusion: Herbal medicine is a potential treatment for sleep disorders associated with Parkinson’s disease. However, the selected RCTs were of poor quality, and it is necessary to perform more systematic studies.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135082882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case Report on the Five-year Survival of a Patient with Rectal Cancer Treated with Integrative Medicine After Resection and Chemoradiation Therapy 1例直肠癌经中西医结合手术切除加放化疗后5年生存率分析
Pub Date : 2023-06-30 DOI: 10.22246/jikm.2023.44.3.578
B. Jeong, Jisoo Kim, Y. Jung, Kyung-dug Park, Yoona Oh, Sunhwi Bang
Objectives: This is a five-year survival and complete response (CR) report on rectal cancer treated with western medicine and Korean traditional medicine.Method: A 25-year-old woman diagnosed with rectal cancer visited ○○ Korean traditional medicine hospital after neoadjuvant concurrent chemoradiation therapy, chemotherapy, and low anterior resection with regional lymph node dissection. She was treated with Korean traditional medicine, including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, and herbal medicine, which was based on integrated medicine therapy (IMT), from January 2018 to February 2022. The tumor size was measured by scanning with computed tomography (CT), magnetic resonance imaging, and positron-emission tomography/CT. Adverse events were evaluated using laboratory conclusion and National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0.Result: During four years of treatment, IMT maintained safety. The patient finally reached five-year survival without any recurrence or complication (CR) on March 11, 2022.Conclusion: We suggest that an integrative approach including Korean traditional medicine can be a meaningful treatment option for rectal cancer. Further studies should be performed to establish the proper treatment protocol of integrative medicine for rectal cancer.
目的:这是一份西药和韩药治疗直肠癌的5年生存和完全缓解(CR)报告。方法:一名25岁的直肠癌患者在接受新辅助同步放化疗、化疗、低位前切除术并区域淋巴结清扫后到〇〇韩国中医院就诊。从2018年1月到2022年2月,她接受了针灸、腹灸、野生人参药物穿刺、以综合医学疗法(IMT)为基础的草药等韩国传统医学的治疗。通过计算机断层扫描(CT)、磁共振成像和正电子发射断层扫描/CT测量肿瘤大小。不良事件采用实验室结论和美国国家癌症研究所不良事件通用术语标准5.0版进行评估。结果:在4年的治疗中,IMT保持了安全性。患者最终于2022年3月11日达到5年生存期,无复发或并发症(CR)。结论:我们认为结合韩国传统医学治疗直肠癌是一种有意义的治疗选择。需要进一步的研究来建立合适的直肠癌中西医结合治疗方案。
{"title":"Case Report on the Five-year Survival of a Patient with Rectal Cancer Treated with Integrative Medicine After Resection and Chemoradiation Therapy","authors":"B. Jeong, Jisoo Kim, Y. Jung, Kyung-dug Park, Yoona Oh, Sunhwi Bang","doi":"10.22246/jikm.2023.44.3.578","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.3.578","url":null,"abstract":"Objectives: This is a five-year survival and complete response (CR) report on rectal cancer treated with western medicine and Korean traditional medicine.Method: A 25-year-old woman diagnosed with rectal cancer visited ○○ Korean traditional medicine hospital after neoadjuvant concurrent chemoradiation therapy, chemotherapy, and low anterior resection with regional lymph node dissection. She was treated with Korean traditional medicine, including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, and herbal medicine, which was based on integrated medicine therapy (IMT), from January 2018 to February 2022. The tumor size was measured by scanning with computed tomography (CT), magnetic resonance imaging, and positron-emission tomography/CT. Adverse events were evaluated using laboratory conclusion and National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0.Result: During four years of treatment, IMT maintained safety. The patient finally reached five-year survival without any recurrence or complication (CR) on March 11, 2022.Conclusion: We suggest that an integrative approach including Korean traditional medicine can be a meaningful treatment option for rectal cancer. Further studies should be performed to establish the proper treatment protocol of integrative medicine for rectal cancer.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85869165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver Protective Effect of the Co-treatment of Rhei Radix et Rhizoma and Silymarin on TAA-induced Liver Injury 大黄、水飞蓟素对taa所致肝损伤的保护作用
Pub Date : 2023-06-30 DOI: 10.22246/jikm.2023.44.3.402
Il-ha Jeong, Sang-woo Ji, S. Roh
Objective: Liver fibrosis is a highly conserved wound-healing response and the final common pathway of chronic inflammatory injury. This study aimed to evaluate the potential anti-fibrotic effect of the combination of Rhei Radix et Rhizoma water extract (RW) and silymarin in a thioacetamide (TAA)-induced liver fibrosis model.Methods: The liver fibrosis mouse model was established through the intraperitoneal injection of TAA (1 week 100 mg/kg, 2-3 weeks 200 mg/kg, 4-8 weeks 400 mg/kg) three times per week for eight weeks. Animal experiments were conducted in five groups; Normal, Control (TAA-induced liver fibrosis mice), Sily (silymarin 50 mg/kg), RSL (RW 50 mg/kg+silymarin 50 mg/kg), and RSH (RW 100 mg/kg+silymarin 50 mg/kg). Biochemical analyses were measured in serum, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), malondialdehyde (MDA), and ammonia levels. Liver inflammatory cytokines and fibrous biomarkers were measured by Western blot analysis, and liver histopathology was evaluated through tissue staining.Results: A significant decrease in the liver function markers AST and ALT and a reduction in ammonia and total bilirubin were observed in the group treated with RSL and RSH. Measurement of reactive oxygen species and MDA revealed a significant decrease in the RSL and RSH administration group compared to the TAA induction group. The expression of extracellular matrix-related proteins, such as transforming growth factor β1, α-smooth muscle actin, and collagen type I alpha 1, was likewise significantly decreased. All drug-administered groups had increased matrix metalloproteinase-9 but a decreasing tissue inhibitor of matrix metalloproteinase-1. RSL and RSH exerted a significant upregulation of NADPH oxidase 2, p22phox, and p47phox, which are oxidative stress-related factors. Furthermore, pro-inflammatory proteins such as cyclooxygenase 2 and interleukin-1β were markedly suppressed through the inhibition of nuclear factor kappa B activation.Conclusions: The administration of RW and silymarin suppressed the NADPH oxidase factor protein level and showed a tendency to reduce inflammation-related enzymes. These results suggest that the combined administration of RW and silymarin improves acute liver injury induced by TAA.
目的:肝纤维化是一种高度保守的创面愈合反应,是慢性炎症损伤的最终共同途径。本研究旨在探讨大黄水提物(RW)与水飞蓟素联合应用对硫乙酰胺(TAA)诱导肝纤维化模型的潜在抗纤维化作用。方法:采用TAA腹腔注射(1周100 mg/kg, 2-3周200 mg/kg, 4-8周400 mg/kg),每周3次,连续8周建立肝纤维化小鼠模型。动物实验分为五组;正常小鼠、对照组(taa诱导肝纤维化小鼠)、茜茜(水飞蓟素50 mg/kg)、RSL (RW 50 mg/kg+水飞蓟素50 mg/kg)、RSH (RW 100 mg/kg+水飞蓟素50 mg/kg)。测定血清生化指标,包括天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、丙二醛(MDA)和氨水平。Western blot法检测肝脏炎症因子和纤维生物标志物,组织染色法评价肝脏组织病理学。结果:RSL和RSH治疗组肝功能指标AST和ALT明显降低,氨氮和总胆红素明显降低。与TAA诱导组相比,RSL和RSH给药组的活性氧和MDA含量显著降低。细胞外基质相关蛋白,如转化生长因子β1、α-平滑肌肌动蛋白和I型胶原α 1的表达也显著降低。各给药组基质金属蛋白酶-9升高,基质金属蛋白酶-1组织抑制剂降低。RSL和RSH显著上调NADPH氧化酶2、p22phox、p47phox等氧化应激相关因子。此外,通过抑制核因子κ B的激活,促炎蛋白如环氧合酶2和白细胞介素-1β明显受到抑制。结论:RW联合水飞蓟素可抑制NADPH氧化酶因子蛋白水平,并有降低炎症相关酶的趋势。上述结果提示,水飞蓟素与RW联合用药可改善TAA所致急性肝损伤。
{"title":"Liver Protective Effect of the Co-treatment of Rhei Radix et Rhizoma and Silymarin on TAA-induced Liver Injury","authors":"Il-ha Jeong, Sang-woo Ji, S. Roh","doi":"10.22246/jikm.2023.44.3.402","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.3.402","url":null,"abstract":"Objective: Liver fibrosis is a highly conserved wound-healing response and the final common pathway of chronic inflammatory injury. This study aimed to evaluate the potential anti-fibrotic effect of the combination of Rhei Radix et Rhizoma water extract (RW) and silymarin in a thioacetamide (TAA)-induced liver fibrosis model.Methods: The liver fibrosis mouse model was established through the intraperitoneal injection of TAA (1 week 100 mg/kg, 2-3 weeks 200 mg/kg, 4-8 weeks 400 mg/kg) three times per week for eight weeks. Animal experiments were conducted in five groups; Normal, Control (TAA-induced liver fibrosis mice), Sily (silymarin 50 mg/kg), RSL (RW 50 mg/kg+silymarin 50 mg/kg), and RSH (RW 100 mg/kg+silymarin 50 mg/kg). Biochemical analyses were measured in serum, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), malondialdehyde (MDA), and ammonia levels. Liver inflammatory cytokines and fibrous biomarkers were measured by Western blot analysis, and liver histopathology was evaluated through tissue staining.Results: A significant decrease in the liver function markers AST and ALT and a reduction in ammonia and total bilirubin were observed in the group treated with RSL and RSH. Measurement of reactive oxygen species and MDA revealed a significant decrease in the RSL and RSH administration group compared to the TAA induction group. The expression of extracellular matrix-related proteins, such as transforming growth factor β1, α-smooth muscle actin, and collagen type I alpha 1, was likewise significantly decreased. All drug-administered groups had increased matrix metalloproteinase-9 but a decreasing tissue inhibitor of matrix metalloproteinase-1. RSL and RSH exerted a significant upregulation of NADPH oxidase 2, p22phox, and p47phox, which are oxidative stress-related factors. Furthermore, pro-inflammatory proteins such as cyclooxygenase 2 and interleukin-1β were markedly suppressed through the inhibition of nuclear factor kappa B activation.Conclusions: The administration of RW and silymarin suppressed the NADPH oxidase factor protein level and showed a tendency to reduce inflammation-related enzymes. These results suggest that the combined administration of RW and silymarin improves acute liver injury induced by TAA.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"92 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79989625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of GGX on an Ovalbumin-induced Asthma Mice Model GGX对卵清蛋白诱导哮喘小鼠模型的影响
Pub Date : 2023-06-30 DOI: 10.22246/jikm.2023.44.3.294
Tae-hyeon Kim, Won-Kyung Yang, Su-Won Lee, Seong-Cheon Woo, S. Kim, Yang-Chun Park
Objective: The purpose of this study is to evaluate the effects of GGX on an ovalbumin (OVA)-induced asthma mice model.Methods: Balb/c mice were challenged with OVA and then treated with three concentrations of GGX (100, 200, and 400 mg/kg). After sacrifice, the bronchoalveolar lavage fluid (BALF) or lungs of the mice were analyzed by fluorescence-activated cell sorting, ELISA, real-time PCR, H&E, Masson’s trichrome, PAS and AB-PAS staining, and immunohistofluorescence staining.Results: GGX significantly inhibited the increase of total cells, immune cells (lymphocyte, neutrophils, macrophage, CD4+, CD8+, CD4+CD69+, CD62L-CD44high+, Gr-1+SiglecF-), and the expression of cytokines (IL-4, IL-5, IL-13, IFN-γ) in BALF. It also significantly inhibited the increase of total cells, immune cells (lymphocyte, neutrophils, eosinophil/macrophage, CD3+, CD19+, CD3+CD193+, CD4+, CD8+, CD4+CD69+, CD62L-CD44high+, and Gr-1+SiglecF-), and the expression of IL-13, TARC, and MCP-1 in lung tissue. GGX decreased the severity of histological lung injury and the expressions of STAT3 and GATA3.Conclusion: This study suggests the probability of using GGX for the treatment of asthma by inhibiting inflammatory immune response.
目的:探讨GGX对卵清蛋白(OVA)诱导的哮喘小鼠模型的影响。方法:Balb/c小鼠经OVA攻毒后,分别给予100mg /kg、200mg /kg、400mg /kg三种浓度的GGX处理。牺牲后,采用荧光活化细胞分选、ELISA、real-time PCR、H&E、Masson’s三色、PAS和AB-PAS染色、免疫组织荧光染色等方法分析小鼠支气管肺泡灌洗液(BALF)或肺组织。结果:GGX显著抑制BALF中总细胞、免疫细胞(淋巴细胞、中性粒细胞、巨噬细胞、CD4+、CD8+、CD4+CD69+、CD62L-CD44high+、Gr-1+SiglecF-)和细胞因子(IL-4、IL-5、IL-13、IFN-γ)表达的增加。显著抑制肺组织中总细胞、免疫细胞(淋巴细胞、中性粒细胞、嗜酸性粒细胞/巨噬细胞、CD3+、CD19+、CD3+CD193+、CD4+、CD8+、CD4+CD69+、CD62L-CD44high+、Gr-1+SiglecF-)、IL-13、TARC、MCP-1表达的增加。GGX降低了肺组织损伤的严重程度和STAT3、GATA3的表达。结论:本研究提示GGX通过抑制炎症免疫反应治疗哮喘的可能性。
{"title":"Effects of GGX on an Ovalbumin-induced Asthma Mice Model","authors":"Tae-hyeon Kim, Won-Kyung Yang, Su-Won Lee, Seong-Cheon Woo, S. Kim, Yang-Chun Park","doi":"10.22246/jikm.2023.44.3.294","DOIUrl":"https://doi.org/10.22246/jikm.2023.44.3.294","url":null,"abstract":"Objective: The purpose of this study is to evaluate the effects of GGX on an ovalbumin (OVA)-induced asthma mice model.Methods: Balb/c mice were challenged with OVA and then treated with three concentrations of GGX (100, 200, and 400 mg/kg). After sacrifice, the bronchoalveolar lavage fluid (BALF) or lungs of the mice were analyzed by fluorescence-activated cell sorting, ELISA, real-time PCR, H&E, Masson’s trichrome, PAS and AB-PAS staining, and immunohistofluorescence staining.Results: GGX significantly inhibited the increase of total cells, immune cells (lymphocyte, neutrophils, macrophage, CD4+, CD8+, CD4+CD69+, CD62L-CD44high+, Gr-1+SiglecF-), and the expression of cytokines (IL-4, IL-5, IL-13, IFN-γ) in BALF. It also significantly inhibited the increase of total cells, immune cells (lymphocyte, neutrophils, eosinophil/macrophage, CD3+, CD19+, CD3+CD193+, CD4+, CD8+, CD4+CD69+, CD62L-CD44high+, and Gr-1+SiglecF-), and the expression of IL-13, TARC, and MCP-1 in lung tissue. GGX decreased the severity of histological lung injury and the expressions of STAT3 and GATA3.Conclusion: This study suggests the probability of using GGX for the treatment of asthma by inhibiting inflammatory immune response.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85691834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Journal of Internal Korean Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1